Thilakavathi Chengodu
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reply to Armando Stabile, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Jianliang Liu, Laurence Harewood, Dominic Bagguley, et al. Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer. Eur Urol Oncol 2025;8:1118-25.
Journal: European urology oncology
Published: February 02, 2026
Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate-risk prostate cancer.
Journal: BJU international
Published: July 24, 2025
Prostate specific membrane antigen (PSMA) as a biomarker in early and localized advanced prostate cancer: a narrative review.
Journal: The Canadian journal of urology
Published: June 10, 2025
Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer.
Journal: European urology oncology
Published: November 17, 2024
Exploring the utility of artificial intelligence in identifying progression of prostate cancer during active surveillance: A systematic review.
Journal: Prostate cancer and prostatic diseases
Published: October 15, 2024
The CONFIRM trial protocol: the utility of prostate-specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer.
Journal: BJU international
Published: October 31, 2023
Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer-a systematic review and meta-analysis.
Journal: Prostate cancer and prostatic diseases
Published: August 21, 2023
Irreversible Electroporation for Prostate Cancer.
Journal: Life (Basel, Switzerland)
Published: March 30, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026